Skip to main content
Top
Published in: BMC Public Health 1/2013

Open Access 01-12-2013 | Research article

Evidence for cervical cancer mortality with screening program in Taiwan, 1981–2010: age-period-cohort model

Authors: Shih-Yung Su, Jing-Yang Huang, Chien-Chang Ho, Yung-Po Liaw

Published in: BMC Public Health | Issue 1/2013

Login to get access

Abstract

Background

Cervical cancer is the most common cancer experienced by women worldwide; however, screening techniques are very effective for reducing the risk of death. The national cervical cancer screening program was implemented in Taiwan in 1995. The objective of this study was to examine and provide evidence of the cervical cancer mortality trends for the periods before and after the screening program was implemented.

Methods

Data from 1981 to 2010 of the causes of death registered were obtained from the Department of Health, Taiwan. Age-standardized mortality rates, age-specific rates, and age-period-cohort models that employed the sequential method were used to assess temporal changes that occurred between 1981 and 2010, with 1995 used as the separating year.

Results

The results showed that for both time periods of 1981 to 1995 and 1996 to 2010, age and period had significant effects, whereas the birth cohort effects were insignificant. For patients between 80 and 84 years of age, the mortality rate for 1981 to 1995 and 1996 to 2010 was 48.34 and 68.08. The cervical cancer mortality rate for 1996 to 2010 was 1.0 for patients between 75 and 79 years of age and 1.4 for patients between 80 and 84 years of age compared to that for 1981 to 1995. Regarding the period effect, the mortality trend decreased 2-fold from 1996 to 2010.

Conclusions

The results of this study indicate a decline in cervical cancer mortality trends after the screening program involving Papanicolaou tests was implemented in 1995. However, the positive effects of the screening program were not observed in elderly women because of treatment delays during the initial implementation of the screening program.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vinh-Hung V, Bourgain C, Vlastos G, Cserni G, De Ridder M, Storme G, Vlastos AT: Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer. 2007, 7: 164-10.1186/1471-2407-7-164.CrossRefPubMedPubMedCentral Vinh-Hung V, Bourgain C, Vlastos G, Cserni G, De Ridder M, Storme G, Vlastos AT: Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer. 2007, 7: 164-10.1186/1471-2407-7-164.CrossRefPubMedPubMedCentral
2.
go back to reference Lau HY, Juang CM, Chen YJ, Twu NF, Yen MS, Chao KC: Aggressive characteristics of cervical cancer in young women in Taiwan. Int J Gynaecol Obstet. 2009, 107 (3): 220-223. 10.1016/j.ijgo.2009.07.029.CrossRefPubMed Lau HY, Juang CM, Chen YJ, Twu NF, Yen MS, Chao KC: Aggressive characteristics of cervical cancer in young women in Taiwan. Int J Gynaecol Obstet. 2009, 107 (3): 220-223. 10.1016/j.ijgo.2009.07.029.CrossRefPubMed
3.
go back to reference Taylor R, Morrell S, Mamoon H, Wain G, Ross J: Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia). Cancer Causes Control. 2006, 17 (3): 299-306. 10.1007/s10552-005-0515-z.CrossRefPubMed Taylor R, Morrell S, Mamoon H, Wain G, Ross J: Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia). Cancer Causes Control. 2006, 17 (3): 299-306. 10.1007/s10552-005-0515-z.CrossRefPubMed
4.
go back to reference Sigurdsson K: Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in Iceland, 1964–1991. Int J Cancer. 1993, 54: 563-570. 10.1002/ijc.2910540408.CrossRefPubMed Sigurdsson K: Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in Iceland, 1964–1991. Int J Cancer. 1993, 54: 563-570. 10.1002/ijc.2910540408.CrossRefPubMed
5.
go back to reference Day NE: Effect of cervical cancer screening in Scandinavia. Obstet Gynecol. 1984, 63 (5): 714-718.PubMed Day NE: Effect of cervical cancer screening in Scandinavia. Obstet Gynecol. 1984, 63 (5): 714-718.PubMed
6.
go back to reference Hakama M, Louhivuori K: A screening programme for cervical cancer that worked. Cancer Surv. 1988, 7 (3): 403-416.PubMed Hakama M, Louhivuori K: A screening programme for cervical cancer that worked. Cancer Surv. 1988, 7 (3): 403-416.PubMed
7.
go back to reference Nygard JF, Skare GB, Thoresen SO: The cervical cancer screening programme in Norway, 1992–2000: changes in Pap smear coverage and incidence of cervical cancer. J Med Screen. 2002, 9 (2): 86-91. 10.1136/jms.9.2.86.CrossRefPubMed Nygard JF, Skare GB, Thoresen SO: The cervical cancer screening programme in Norway, 1992–2000: changes in Pap smear coverage and incidence of cervical cancer. J Med Screen. 2002, 9 (2): 86-91. 10.1136/jms.9.2.86.CrossRefPubMed
8.
go back to reference Patnick J: Cervical cancer screening in England. Eur J Cancer. 2000, 36 (17): 2205-2208. 10.1016/S0959-8049(00)00310-5.CrossRefPubMed Patnick J: Cervical cancer screening in England. Eur J Cancer. 2000, 36 (17): 2205-2208. 10.1016/S0959-8049(00)00310-5.CrossRefPubMed
9.
go back to reference Schaffer P, Sancho-Garnier H, Fender M, Dellenbach P, Carbillet JP, Monnet E, Gauthier GP, Garnier A: Cervical cancer screening in France. Eur J Cancer. 2000, 36 (17): 2215-2220. 10.1016/S0959-8049(00)00312-9.CrossRefPubMed Schaffer P, Sancho-Garnier H, Fender M, Dellenbach P, Carbillet JP, Monnet E, Gauthier GP, Garnier A: Cervical cancer screening in France. Eur J Cancer. 2000, 36 (17): 2215-2220. 10.1016/S0959-8049(00)00312-9.CrossRefPubMed
10.
go back to reference Siebert U, Sroczynski G, Hillemanns P, Engel J, Stabenow R, Stegmaier C, Voigt K, Gibis B, Holzel D, Goldie SJ: The German cervical cancer screening model: development and validation of a decision-analytic model for cervical cancer screening in Germany. Eur J Public Health. 2006, 16 (2): 185-192.CrossRefPubMed Siebert U, Sroczynski G, Hillemanns P, Engel J, Stabenow R, Stegmaier C, Voigt K, Gibis B, Holzel D, Goldie SJ: The German cervical cancer screening model: development and validation of a decision-analytic model for cervical cancer screening in Germany. Eur J Public Health. 2006, 16 (2): 185-192.CrossRefPubMed
11.
go back to reference Armour BS, Thierry JM, Wolf LA: State-level differences in breast and cervical cancer screening by disability status: United States, 2008. Womens Health Issues. 2009, 19 (6): 406-414. 10.1016/j.whi.2009.08.006.CrossRefPubMed Armour BS, Thierry JM, Wolf LA: State-level differences in breast and cervical cancer screening by disability status: United States, 2008. Womens Health Issues. 2009, 19 (6): 406-414. 10.1016/j.whi.2009.08.006.CrossRefPubMed
12.
go back to reference Latif E: Recent immigrants and the use of cervical cancer screening test in Canada. J Immigr Minor Health. 2010, 12 (1): 1-17. 10.1007/s10903-009-9237-8.CrossRefPubMed Latif E: Recent immigrants and the use of cervical cancer screening test in Canada. J Immigr Minor Health. 2010, 12 (1): 1-17. 10.1007/s10903-009-9237-8.CrossRefPubMed
13.
go back to reference Wang PD, Lin RS: Epidemiology of cervical cancer in Taiwan. Gynecol Oncol. 1996, 62 (3): 344-352. 10.1006/gyno.1996.0247.CrossRefPubMed Wang PD, Lin RS: Epidemiology of cervical cancer in Taiwan. Gynecol Oncol. 1996, 62 (3): 344-352. 10.1006/gyno.1996.0247.CrossRefPubMed
14.
go back to reference Carstensen B: Age-period-cohort models for the Lexis diagram. Stat Med. 2007, 26 (15): 3018-3045. 10.1002/sim.2764.CrossRefPubMed Carstensen B: Age-period-cohort models for the Lexis diagram. Stat Med. 2007, 26 (15): 3018-3045. 10.1002/sim.2764.CrossRefPubMed
15.
go back to reference Chen YY, You SL, Chen CA, Shih LY, Koong SL, Chao KY, Hsiao ML, Hsieh CY, Chen CJ: Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences. Br J Cancer. 2009, 101 (1): 174-177. 10.1038/sj.bjc.6605139.CrossRefPubMedPubMedCentral Chen YY, You SL, Chen CA, Shih LY, Koong SL, Chao KY, Hsiao ML, Hsieh CY, Chen CJ: Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences. Br J Cancer. 2009, 101 (1): 174-177. 10.1038/sj.bjc.6605139.CrossRefPubMedPubMedCentral
16.
go back to reference Koong SL, Yen AM, Chen TH: Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan. J Med Screen. 2006, 13 (Suppl 1): S44-S47.PubMed Koong SL, Yen AM, Chen TH: Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan. J Med Screen. 2006, 13 (Suppl 1): S44-S47.PubMed
17.
go back to reference Chang JI, Ou CH, Wu KM, Chen CC, Cheng KC: The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan. Zhonghua Yi Xue Za Zhi (Taipei). 2002, 65 (9): 430-434.PubMed Chang JI, Ou CH, Wu KM, Chen CC, Cheng KC: The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan. Zhonghua Yi Xue Za Zhi (Taipei). 2002, 65 (9): 430-434.PubMed
18.
go back to reference Chen LS, Huang N, Tsay JH, Wang PJ, Chou YJ, Chou P, Lee CH: Screening for cervical cancer among female physicians and their relatives in Taiwan: a population-based comparative study. Prev Med. 2007, 44 (6): 531-535. 10.1016/j.ypmed.2007.02.001.CrossRefPubMed Chen LS, Huang N, Tsay JH, Wang PJ, Chou YJ, Chou P, Lee CH: Screening for cervical cancer among female physicians and their relatives in Taiwan: a population-based comparative study. Prev Med. 2007, 44 (6): 531-535. 10.1016/j.ypmed.2007.02.001.CrossRefPubMed
19.
go back to reference Louie KS, de Sanjose S, Diaz M, Castellsague X, Herrero R, Meijer CJ, Shah K, Franceschi S, Munoz N, Bosch FX: Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer. 2009, 100 (7): 1191-1197. 10.1038/sj.bjc.6604974.CrossRefPubMedPubMedCentral Louie KS, de Sanjose S, Diaz M, Castellsague X, Herrero R, Meijer CJ, Shah K, Franceschi S, Munoz N, Bosch FX: Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer. 2009, 100 (7): 1191-1197. 10.1038/sj.bjc.6604974.CrossRefPubMedPubMedCentral
20.
go back to reference Bosch FX, Munoz N, de Sanjose S, Izarzugaza I, Gili M, Viladiu P, Tormo MJ, Moreo P, Ascunce N, Gonzalez LC, et al: Risk factors for cervical cancer in Colombia and Spain. Int J Cancer. 1992, 52 (5): 750-758. 10.1002/ijc.2910520514.CrossRefPubMed Bosch FX, Munoz N, de Sanjose S, Izarzugaza I, Gili M, Viladiu P, Tormo MJ, Moreo P, Ascunce N, Gonzalez LC, et al: Risk factors for cervical cancer in Colombia and Spain. Int J Cancer. 1992, 52 (5): 750-758. 10.1002/ijc.2910520514.CrossRefPubMed
21.
go back to reference Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, et al: HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer. 2001, 84 (9): 1219-1226. 10.1054/bjoc.2001.1779.CrossRefPubMedPubMedCentral Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, et al: HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer. 2001, 84 (9): 1219-1226. 10.1054/bjoc.2001.1779.CrossRefPubMedPubMedCentral
22.
go back to reference Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX: Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case–control study. Lancet. 2002, 359 (9312): 1093-1101. 10.1016/S0140-6736(02)08151-5.CrossRefPubMed Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX: Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case–control study. Lancet. 2002, 359 (9312): 1093-1101. 10.1016/S0140-6736(02)08151-5.CrossRefPubMed
23.
go back to reference Walter LC, Lewis CL, Barton MB: Screening for colorectal, breast, and cervical cancer in the elderly: a review of the evidence. Am J Med. 2005, 118 (10): 1078-1086. 10.1016/j.amjmed.2005.01.063.CrossRefPubMed Walter LC, Lewis CL, Barton MB: Screening for colorectal, breast, and cervical cancer in the elderly: a review of the evidence. Am J Med. 2005, 118 (10): 1078-1086. 10.1016/j.amjmed.2005.01.063.CrossRefPubMed
24.
go back to reference Baay MF, Smits E, Tjalma WA, Lardon F, Weyler J, Van Royen P, Van Marck EA, Vermorken JB: Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women. Int J Cancer. 2004, 108 (2): 258-261. 10.1002/ijc.11543.CrossRefPubMed Baay MF, Smits E, Tjalma WA, Lardon F, Weyler J, Van Royen P, Van Marck EA, Vermorken JB: Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women. Int J Cancer. 2004, 108 (2): 258-261. 10.1002/ijc.11543.CrossRefPubMed
25.
go back to reference Lichtman SM: Geriatric oncology: cervical cancer screening in elderly women. N Y State J Med. 1991, 91 (4): 147-149.PubMed Lichtman SM: Geriatric oncology: cervical cancer screening in elderly women. N Y State J Med. 1991, 91 (4): 147-149.PubMed
26.
27.
go back to reference Fahs MC, Mandelblatt J, Schechter C, Muller C: Cost effectiveness of cervical cancer screening for the elderly. Ann Intern Med. 1992, 117 (6): 520-527.CrossRefPubMed Fahs MC, Mandelblatt J, Schechter C, Muller C: Cost effectiveness of cervical cancer screening for the elderly. Ann Intern Med. 1992, 117 (6): 520-527.CrossRefPubMed
28.
go back to reference Llorca J, Rodriguez-Cundin P, Dierssen-Sotos T, Prieto-Salceda D: Cervical cancer mortality is increasing in Spanish women younger than 50. Cancer Lett. 2006, 240 (1): 36-40. 10.1016/j.canlet.2005.08.021.CrossRefPubMed Llorca J, Rodriguez-Cundin P, Dierssen-Sotos T, Prieto-Salceda D: Cervical cancer mortality is increasing in Spanish women younger than 50. Cancer Lett. 2006, 240 (1): 36-40. 10.1016/j.canlet.2005.08.021.CrossRefPubMed
29.
go back to reference Cuzick J, Boyle P: Trends in cervix cancer mortality. Cancer Surv. 1988, 7 (3): 417-439.PubMed Cuzick J, Boyle P: Trends in cervix cancer mortality. Cancer Surv. 1988, 7 (3): 417-439.PubMed
30.
go back to reference Beral V, Hermon C, Munoz N, Devesa SS: Cervical cancer. Cancer Surv. 1994, 19–20: 265-285.PubMed Beral V, Hermon C, Munoz N, Devesa SS: Cervical cancer. Cancer Surv. 1994, 19–20: 265-285.PubMed
31.
go back to reference Levi F, Lucchini F, Negri E, Franceschi S, la Vecchia C: Cervical cancer mortality in young women in Europe: patterns and trends. Eur J Cancer. 2000, 36 (17): 2266-2271. 10.1016/S0959-8049(00)00346-4. 14. Lu THCrossRefPubMed Levi F, Lucchini F, Negri E, Franceschi S, la Vecchia C: Cervical cancer mortality in young women in Europe: patterns and trends. Eur J Cancer. 2000, 36 (17): 2266-2271. 10.1016/S0959-8049(00)00346-4. 14. Lu THCrossRefPubMed
32.
go back to reference Lee MC, Chou MC: Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics. Int J Epidemiol. 2000, 29 (2): 336-343. 10.1093/ije/29.2.336.CrossRefPubMed Lee MC, Chou MC: Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics. Int J Epidemiol. 2000, 29 (2): 336-343. 10.1093/ije/29.2.336.CrossRefPubMed
Metadata
Title
Evidence for cervical cancer mortality with screening program in Taiwan, 1981–2010: age-period-cohort model
Authors
Shih-Yung Su
Jing-Yang Huang
Chien-Chang Ho
Yung-Po Liaw
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2013
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-13-13

Other articles of this Issue 1/2013

BMC Public Health 1/2013 Go to the issue